| Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics GR Kokil, RN Veedu, GA Ramm, JB Prins, HS Parekh Chemical Reviews 115 (11), 4719-4743, 2015 | 99 | 2015 |
| Novel chromeneimidazole derivatives as antifungal compounds: synthesis and in vitro evaluation S Thareja, A Verma, A Kalra, S Gosain, PV Rewatkar, GR Kokil Acta Pol Pharm 67, 423-427, 2010 | 87 | 2010 |
| Pharmacology and chemistry of diabetes mellitus and antidiabetic drugs: A critical review G R Kokil, P V Rewatkar, A Verma, S Thareja, S R Naik Current medicinal chemistry 17 (35), 4405-4423, 2010 | 65 | 2010 |
| Synthesis and in vitro evaluation of novel 1, 2, 4-triazole derivatives as antifungal agents GR Kokil, PV Rewatkar, S Gosain, S Aggarwal, A Verma, A Kalra, ... Letters in Drug Design & Discovery 7 (1), 46-49, 2010 | 64 | 2010 |
| Skin delivery of EGCG and silibinin: potential of peptide dendrimers for enhanced skin permeation and deposition PK Shetty, J Manikkath, K Tupally, G Kokil, AR Hegde, SY Raut, ... AAPS PharmSciTech 18, 2346-2357, 2017 | 57 | 2017 |
| Inorganic/organic combination: inorganic particles/polymer composites for tissue engineering applications A Sharma, GR Kokil, Y He, B Lowe, A Salam, TA Altalhi, Q Ye, T Kumeria Bioactive materials 24, 535-550, 2023 | 36 | 2023 |
| Bioprecursor Prodrugs: Molecular Modification of the Active Principle G R Kokil, P V Rewatkar Mini Reviews in Medicinal Chemistry 10 (14), 1316-1330, 2010 | 35 | 2010 |
| Self-assembling asymmetric peptide-dendrimer micelles – a platform for effective and versatile in vitro nucleic acid delivery GR Kokil, RN Veedu, BT Le, GA Ramm, HS Parekh Scientific Reports 8 (1), 4832, 2018 | 26 | 2018 |
| Nonordered dendritic mesoporous silica nanoparticles as promising platforms for advanced methods of diagnosis and therapies S Malekmohammadi, RUR Mohammed, H Samadian, A Zarebkohan, ... Materials Today Chemistry 26, 101144, 2022 | 24 | 2022 |
| Chapter 12 – Development and Discovery Avenues in Bioactive Natural Products for Glycemic Novel Therapeutics SR Naik, GR Kokil Studies in Natural Products Chemistry 39, 431-466, 2013 | 21 | 2013 |
| Oseltamivir: A First Line Defense Against Swine Flu R Agrawal, P V Rewatkar, G R Kokil, A Verma, A Kalra Medicinal Chemistry 6 (4), 247-251, 2010 | 19 | 2010 |
| Sulphonamides as inhibitors of protein tyrosine phosphatase 1B: A three-dimensional quantitative structure–activity relationship study using self-organizing molecular field … S Thareja, GR Kokil, S Aggarwal, TR Bhardwaj, M Kumar Chemical and Pharmaceutical Bulletin 58 (4), 526-532, 2010 | 19 | 2010 |
| Rheumatoid arthritis: a new challenge in coming era. PV Rewatkar, GR Kokil, A Verma, S Thareja Mini reviews in medicinal chemistry 10 (2), 98-107, 2010 | 17 | 2010 |
| Microencapsulated islet-like microtissues with toroid geometry for enhanced cellular viability Y Chen, DT Nguyen, GR Kokil, YX Wong, TT Dang Acta Biomaterialia 97, 260-271, 2019 | 11 | 2019 |
| Cerium Oxide Nanoparticles with Entrapped Gadolinium for High T1 Relaxivity and ROS-Scavenging Purposes P Eriksson, AHT Truong, C Brommesson, A Du Rietz, GR Kokil, RD Boyd, ... ACS omega 7 (24), 21337-21345, 2022 | 10 | 2022 |
| Development of a hybrid peptide dendrimer micellar carrier system and its application in the reformulation of a hydrophobic therapeutic agent derived from traditional Chinese … J Jing, KR Tupally, GR Kokil, Z Qu, S Chen, HS Parekh RSC advances 9 (5), 2458-2463, 2019 | 9 | 2019 |
| Shell properties and concentration stability of acoustofluidic delivery agents H Alsadiq, K Tupally, R Vogel, G Kokil, HS Parekh, M Veidt Physical and Engineering Sciences in Medicine 44, 79-91, 2021 | 7 | 2021 |
| QSAR studies of phthalazinones: novel inhibitors of poly (ADP-ribose) polymerase PV Rewatkar, GR Kokil, MK Raut Medicinal Chemistry Research 20, 877-886, 2011 | 7 | 2011 |
| Dendrimers KR Tupally, GR Kokil, SS Thakur, P Singh, HS Parekh Controlled release systems: advances in nanobottles and active nanoparticles, 2015 | 5 | 2015 |
| Direct and Indirect Drug Design Approaches for the Development of Novel Tricyclic Antipsychotics: Potential 5‐HT2A Antagonist MN Jadhav, GR Kokil, SS Harak, SB Wagh Journal of Chemistry 2013 (1), 930354, 2013 | 5 | 2013 |
Harendra ParekhThe University of Queensland在 uq.edu.au 的电子邮件经过验证
